Benevich Eric

Avg. Two Year Performance

No purchase track record
(6%) Avg. Sale Return
(3%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(3%)(12%)(3%)(3%)(6%)
Sale Success Rate5 of 145 of 142 of 141 of 140 of 14
Drugs » Biotechnology

Chief Commercial Officer:

Holdings: 40.78K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--